Grufity logo
Grufity logo

Latest Foresite Capital Management V, LLC Stock Portfolio

$362Million | No. of Holdings #9

Foresite Capital Management V, LLC Performance

2026 Q2+19.33%
YTD+69.64%
2025+44.20%

About Foresite Capital Management V, LLC and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Foresite Capital Management V, LLC reported an equity portfolio of $362.2 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Foresite Capital Management V, LLC are , , . The fund has invested 45.8% of it's portfolio in ALUMIS INC. and 21.2% of portfolio in CG ONCOLOGY, INC. <br><br> The fund managers got completely rid off MAZE THERAPEUTICS, INC. stocks. They significantly reduced their stock positions in LYELL IMMUNOPHARMA, INC. (LYEL). Foresite Capital Management V, LLC opened new stock positions in ODYSSEY THERAPEUTICS, INC.. The fund showed a lot of confidence in some stocks as they added substantially to PHARVARIS N.V. (PHVS) and CG ONCOLOGY, INC..
Foresite Capital Management V, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$362Million
  as of Aug 14, 2026

Foresite Capital Management V, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Foresite Capital Management V, LLC made a return of 19.33% in the last quarter. In trailing 12 months, it's portfolio return was 212.87%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
odyssey therapeutics, inc.13,342,200
New stocks bought by Foresite Capital Management V, LLC

Additions

Ticker% Inc.
pharvaris n.v.242
cg oncology, inc.7.47
Additions to existing portfolio by Foresite Capital Management V, LLC

Reductions

Ticker% Reduced
lyell immunopharma, inc.-0.15
Foresite Capital Management V, LLC reduced stake in above stock

Sold off

Ticker$ Sold
maze therapeutics, inc.-773,264
Foresite Capital Management V, LLC got rid off the above stocks

Sector Distribution

Foresite Capital Management V, LLC has about 89.3% of it's holdings in Others sector.

  • Others
  • Consumer Defensive
  • Healthcare
Sector%
Others89.3
Consumer Defensive7.1
Healthcare3.6

Market Cap. Distribution

Foresite Capital Management V, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • MID-CAP
  • SMALL-CAP
Category%
UNALLOCATED89.3
MID-CAP8.8
SMALL-CAP1.8

Stocks belong to which Index?

About 10.7% of the stocks held by Foresite Capital Management V, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others89.3
RUSSELL 200010.7
Top 5 Winners (%)%
HIMS
hims & hers health, inc.
67.0 %
NRIX
nurix therapeutics, inc.
56.5 %
alumis inc.
27.7 %
eikon therapeutics, inc.
23.4 %
disc medicine, inc.
14.4 %
Top 5 Winners ($)$
alumis inc.
36.0 M
HIMS
hims & hers health, inc.
10.3 M
cg oncology, inc.
3.5 M
disc medicine, inc.
3.4 M
eikon therapeutics, inc.
3.3 M
Top 5 Losers (%)%
LYEL
lyell immunopharma, inc.
-29.9 %
Top 5 Losers ($)$
LYEL
lyell immunopharma, inc.
-2.9 M

Foresite Capital Management V, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Foresite Capital Management V, LLC

Foresite Capital Management V, LLC has 9 stocks in it's portfolio. LYEL proved to be the most loss making stock for the portfolio. was the most profitable stock for Foresite Capital Management V, LLC last quarter.

$362.20MTotal Value
10.00Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Foresite Capital Management V, LLC, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
PHVS
Pharvaris N.V.

Pharvaris N.V.

PHVS
Foresite Capital Management V, LLC's holding in Pharvaris N.V. over time
6.34%664,142
$22.97M
6.34%
increased 242.12 percentadded
Com
Alumis Inc.

Alumis Inc.

Foresite Capital Management V, LLC's holding in Alumis Inc. over time
45.81%5,897,000
$165.94M
45.81%
unchanged 0 percentunchanged
Com
Cg Oncology, Inc.

Cg Oncology, Inc.

Foresite Capital Management V, LLC's holding in Cg Oncology, Inc. over time
21.17%1,079,050
$76.67M
21.17%
increased 7.47 percentadded
Com
Disc Medicine, Inc.

Disc Medicine, Inc.

Foresite Capital Management V, LLC's holding in Disc Medicine, Inc. over time
7.55%374,069
$27.36M
7.55%
unchanged 0 percentunchanged
Com
Eikon Therapeutics, Inc.

Eikon Therapeutics, Inc.

Foresite Capital Management V, LLC's holding in Eikon Therapeutics, Inc. over time
4.75%1,318,980
$17.21M
4.75%
unchanged 0 percentunchanged
Com
Odyssey Therapeutics, Inc.

Odyssey Therapeutics, Inc.

Foresite Capital Management V, LLC's holding in Odyssey Therapeutics, Inc. over time
3.68%713,105
$13.34M
3.68%
new position
Com
Maze Therapeutics, Inc.

Maze Therapeutics, Inc.

Foresite Capital Management V, LLC's holding in Maze Therapeutics, Inc. over time
0%0.00
$0.00
0%
decreased 100 percentsold off